Avricore Health

Innovative Pharmaceutical Technology

Overview

Avricore Health Inc. (TSXV:AVCR,OTCQB:AVCRF) is a healthcare technology company focused on health innovation in the nutraceutical, medical cannabis and endocannabinoid industries. Using a patient-driven rapid access, safety test reporting system (RASTER) model, Avricore Health has developed HealthTab™, a point-of-care screening system that allows patients to directly measure and monitor the 21 key biomarkers of chronic disease.

The system utilizes Abaxis’ Piccolo Xpress® point of care analyzer, which was initially designed by NASA to test the health of astronauts. HealthTab™ is Health Canada certified and trusted worldwide by medical clinics, physician offices and government health screening programs, among others.

Avricore Health charges approximately $350 for the HealthTab™ software installation, in addition to a monthly fee for the use of the equipment. Avricore Health has installed the system in pharmacies in British Columbia, Alberta and Ontario through various pharmacies, including Shoppers Drug Mart. The company intends to install HealthTab™ in an additional 30 pharmacies in Ontario in the near term, with up to 200 expected within 18 months.

Avricore Health’s Company Highlights

  • Global pharmaceuticals market to reach $1.17 trillion by 2021.
  • Focused on serving the nutraceutical, medical cannabis and endocannabinoid industries.
  • Charges $350 for software installation and a monthly fee for the use of the equipment.
  • HealthTab™ can directly measure and monitor the 21 key biomarkers of chronic diseases.